自我监测血糖市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

自我监测血糖市场按组件(血糖仪设备、试纸和柳叶刀)和地理划分。

市场快照

Self-monitoring Blood Glucose market report Overview
Study Period: 2016-2027
Base Year: 2021
Fastest Growing Market: North America
Largest Market: North America
CAGR: >7 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

自我监测血糖市场预计在预测期间(2021 年至 2026 年)的复合年增长率将超过 8%。到 2026 年,该市场预计将达到 160 亿美元左右。糖尿病患者的主要诊断是血糖水平失衡,不符合标准血糖水平。一般的实验室诊断测试只能帮助医生诊断疾病。血糖波动较大的患者需要每天检查。使用胰岛素的患者需要经常检查自己的血糖水平,以便在必要时调整胰岛素剂量或更换药物,这只有在使用自我监测血糖装置的情况下才有可能。 

报告范围

该报告包括对自我监测血糖设备(包括血糖仪设备、血糖试纸和柳叶刀)和地理的完整研究。

Self-monitoring blood glucose devices
By Component (Value, and Volume, 2016 - 2026)
Glucometer Devices
Test Strips
Lancets
Geography
North America
United States (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Canada (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, Lancets)
Rest of North America (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Europe
France (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Germany (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Italy (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Spain (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
United Kingdom (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Russia (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Rest of Europe (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Latin America
Mexico (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Brazil (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Rest of Latin America (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Asia-Pacific
Japan (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
South Korea (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
China (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
India (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Australia (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Vietnam (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Malaysia (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Indonesia (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Philippines (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Thailand (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Rest of Asia-Pacific (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Middle-East and Africa
Saudi Arabia (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Iran (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Egypt (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Oman (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
South Africa (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)
Rest of Middle-East and Africa (Value, and Volume, 2016 - 2026)
By Component (Glucometer Devices, Test Strips, and Lancets)

Report scope can be customized per your requirements. Click here.

主要市场趋势

大部分 SMBG 市场收入来自血糖试纸

血糖仪是一次性购买的。然而,另一方面,试纸是一项持续投资,因为试纸在使用后需要丢弃。然而,另一方面,试纸被认为是一项持续投资。因此,它对消费者产生了相当大的成本影响。总体而言,预计全球对血糖试纸的需求在预测期内将出现显着增长。预计研究市场的增长将受到全球糖尿病患者人数增加的刺激。由于使用案例频率的差异,预计试纸的市场容量和份额的增长将好于血糖仪。虽然血糖仪的平均使用寿命在 6 个月到 3 年之间,在同一时间范围内呈现一次性成本,

Self-monitoring Blood Glucose Market_Test Strips

在预测期内,北美将继续拥有最大的市场份额

到 2020 年底,北美占糖尿病总人口的 7.7%,占 1 型糖尿病患者总数的 6%。在过去的二十年里,糖尿病的患病率急剧上升,这是由肥胖患病率增加和生活方式改变所驱动的。据估计,北美占全球肥胖人口的 22%。该地区各国的碳水化合物消费量较高,这也是导致肥胖的主要原因之一。在北美,美国是慢性病快速增长的国家之一,也是自测血糖仪需求最大的国家。

Self-monitoring Blood Glucose Market_Region

竞争格局

全球自测血糖市场趋于统一,少数主要制造商在全球市场占有一席之地并占据主要份额,而其余制造商则仅限于其他本地或特定区域的制造商。近期参与者之间发生的并购有助于这些公司加强其市场占有率。松下收购了拜耳的糖尿病护理部门,并将其命名为 Ascensia 糖尿病护理部门,该部门继续在全球范围内开展业务。

RECENT DEVELOPMENTS

In Aug 2021, FIND, announced today that agreements have been signed with i-SENS, Inc (Seoul, South Korea) and SD BIOSENSOR, Inc (Suwon-si, South Korea), to increase low- and middle-income countries (LMIC) access to blood glucose test strips by improving affordability.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Self-monitoring blood glucose devices

      1. 5.1.1 By Component (Value, and Volume, 2016 - 2026)

        1. 5.1.1.1 Glucometer Devices

        2. 5.1.1.2 Test Strips

        3. 5.1.1.3 Lancets

    2. 5.2 Geography

      1. 5.2.1 North America

        1. 5.2.1.1 United States (Value, and Volume, 2016 - 2026)

          1. 5.2.1.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        2. 5.2.1.2 Canada (Value, and Volume, 2016 - 2026)

          1. 5.2.1.2.1 By Component (Glucometer Devices, Test Strips, Lancets)

        3. 5.2.1.3 Rest of North America (Value, and Volume, 2016 - 2026)

          1. 5.2.1.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)

      2. 5.2.2 Europe

        1. 5.2.2.1 France (Value, and Volume, 2016 - 2026)

          1. 5.2.2.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        2. 5.2.2.2 Germany (Value, and Volume, 2016 - 2026)

          1. 5.2.2.2.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        3. 5.2.2.3 Italy (Value, and Volume, 2016 - 2026)

          1. 5.2.2.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        4. 5.2.2.4 Spain (Value, and Volume, 2016 - 2026)

          1. 5.2.2.4.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        5. 5.2.2.5 United Kingdom (Value, and Volume, 2016 - 2026)

          1. 5.2.2.5.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        6. 5.2.2.6 Russia (Value, and Volume, 2016 - 2026)

          1. 5.2.2.6.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        7. 5.2.2.7 Rest of Europe (Value, and Volume, 2016 - 2026)

          1. 5.2.2.7.1 By Component (Glucometer Devices, Test Strips, and Lancets)

      3. 5.2.3 Latin America

        1. 5.2.3.1 Mexico (Value, and Volume, 2016 - 2026)

          1. 5.2.3.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        2. 5.2.3.2 Brazil (Value, and Volume, 2016 - 2026)

          1. 5.2.3.2.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        3. 5.2.3.3 Rest of Latin America (Value, and Volume, 2016 - 2026)

          1. 5.2.3.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)

      4. 5.2.4 Asia-Pacific

        1. 5.2.4.1 Japan (Value, and Volume, 2016 - 2026)

          1. 5.2.4.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        2. 5.2.4.2 South Korea (Value, and Volume, 2016 - 2026)

          1. 5.2.4.2.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        3. 5.2.4.3 China (Value, and Volume, 2016 - 2026)

          1. 5.2.4.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        4. 5.2.4.4 India (Value, and Volume, 2016 - 2026)

          1. 5.2.4.4.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        5. 5.2.4.5 Australia (Value, and Volume, 2016 - 2026)

          1. 5.2.4.5.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        6. 5.2.4.6 Vietnam (Value, and Volume, 2016 - 2026)

          1. 5.2.4.6.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        7. 5.2.4.7 Malaysia (Value, and Volume, 2016 - 2026)

          1. 5.2.4.7.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        8. 5.2.4.8 Indonesia (Value, and Volume, 2016 - 2026)

          1. 5.2.4.8.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        9. 5.2.4.9 Philippines (Value, and Volume, 2016 - 2026)

          1. 5.2.4.9.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        10. 5.2.4.10 Thailand (Value, and Volume, 2016 - 2026)

          1. 5.2.4.10.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        11. 5.2.4.11 Rest of Asia-Pacific (Value, and Volume, 2016 - 2026)

          1. 5.2.4.11.1 By Component (Glucometer Devices, Test Strips, and Lancets)

      5. 5.2.5 Middle-East and Africa

        1. 5.2.5.1 Saudi Arabia (Value, and Volume, 2016 - 2026)

          1. 5.2.5.1.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        2. 5.2.5.2 Iran (Value, and Volume, 2016 - 2026)

          1. 5.2.5.2.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        3. 5.2.5.3 Egypt (Value, and Volume, 2016 - 2026)

          1. 5.2.5.3.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        4. 5.2.5.4 Oman (Value, and Volume, 2016 - 2026)

          1. 5.2.5.4.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        5. 5.2.5.5 South Africa (Value, and Volume, 2016 - 2026)

          1. 5.2.5.5.1 By Component (Glucometer Devices, Test Strips, and Lancets)

        6. 5.2.5.6 Rest of Middle-East and Africa (Value, and Volume, 2016 - 2026)

          1. 5.2.5.6.1 By Component (Glucometer Devices, Test Strips, and Lancets)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes Population (2016 - 2026)

    2. 6.2 Type-2 Diabetes Population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Abbott

      2. 7.1.2 F. Hoffmann-La Roche AG

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Arkray

      5. 7.1.5 Ascensia

      6. 7.1.6 Agamatrix Inc.

      7. 7.1.7 Bionime Corporation

      8. 7.1.8 Acon

      9. 7.1.9 Medisana

      10. 7.1.10 Trivida

      11. 7.1.11 Rossmax

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Self-monitoring Blood Glucose Market market is studied from 2016 - 2027.

The Self-monitoring Blood Glucose Market is growing at a CAGR of >7% over the next 5 years.

The Self-monitoring Blood Glucose Market is valued at 10 Billion USD in 2016.

The Self-monitoring Blood Glucose Market is valued at 16 Billion USD in 2027.

North America is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Lifescan, Ascensia, Arkray, Abbott, F. Hoffmann-La Roche AG are the major companies operating in Self-monitoring Blood Glucose Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!